A detailed history of Huntington National Bank transactions in Care Dx, Inc. stock. As of the latest transaction made, Huntington National Bank holds 2 shares of CDNA stock, worth $48. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$48
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$7.96 - $12.37 $604 - $940
-76 Reduced 97.44%
2 $0
Q4 2023

Feb 07, 2024

BUY
$4.9 - $12.86 $372 - $977
76 Added 3800.0%
78 $0
Q4 2021

Jan 21, 2022

BUY
$41.2 - $73.6 $41 - $73
1 Added 100.0%
2 $0
Q3 2021

Oct 28, 2021

BUY
$59.15 - $91.99 $59 - $91
1 New
1 $0

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.29B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.